A total of 30 febrile neutropenic patients at high risk of gram-negative rod bacteremia and poor prognosis relative to likely response to infection were randomized prospectively to receive granulocyte transfusion within 24 hours of beginning broad spectrum combination antibiotic therapy. Of 16 infected patients receiving granulocytes 11 (69%) improved and of 23 not receiving granulocytes 18 (78%) improved (NSD). Similar results were found for bacteremia (3 of 4 and 6 of 7 improved, respectively). These results do not support the routine early use of granulocyte transfusions in this defined group of neutropenic patients.SCOPUS: NotDefined.jinfo:eu-repo/semantics/publishe
García-Carbonero R, Mayordomo JI, et al. Granulocyte colony-stimulating factor in the treatment of h...
Bacterial and fungal infections still remain an important cause of mortality in patients with hemato...
Despite modern antimicrobials and supportive therapy, bacterial and fungal infections are still majo...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
<div><p>It is still under debate whether granulocyte transfusions (GTs) substantially increase survi...
Granulocyte transfusions (GTs) are seldom used as a life-saving therapy for neutropenic patients wit...
Background: The transfusion of G-CSF-primed granulocytes (GTX) might represent an important treatmen...
Background Despite modern antimicrobials and supportive therapy bacterial and fungal infections are...
Patients with granulocytopenia (granulocyte count less than 0.5 x 109 /L) and a documented infection...
To describe the clinical course of febrile neutropenic pediatric oncology patients undergoing granul...
García-Carbonero R, Mayordomo JI, et al. Granulocyte colony-stimulating factor in the treatment of h...
Bacterial and fungal infections still remain an important cause of mortality in patients with hemato...
Despite modern antimicrobials and supportive therapy, bacterial and fungal infections are still majo...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in p...
<div><p>It is still under debate whether granulocyte transfusions (GTs) substantially increase survi...
Granulocyte transfusions (GTs) are seldom used as a life-saving therapy for neutropenic patients wit...
Background: The transfusion of G-CSF-primed granulocytes (GTX) might represent an important treatmen...
Background Despite modern antimicrobials and supportive therapy bacterial and fungal infections are...
Patients with granulocytopenia (granulocyte count less than 0.5 x 109 /L) and a documented infection...
To describe the clinical course of febrile neutropenic pediatric oncology patients undergoing granul...
García-Carbonero R, Mayordomo JI, et al. Granulocyte colony-stimulating factor in the treatment of h...
Bacterial and fungal infections still remain an important cause of mortality in patients with hemato...
Despite modern antimicrobials and supportive therapy, bacterial and fungal infections are still majo...